Sandoz Group AG

31.01.2024 г., 06:40 ч. UTC

Novartis Net Profit Boosted by Gain From Sandoz Spinoff -- Update

31.01.2024 г., 06:28 ч. UTC

Novartis Net Profit Boosted by Gain From Sandoz Spinoff

22.01.2024 г., 06:44 ч. UTC

Sandoz to Acquire Cimerli Business from Coherus for $170 Million

31.01.2024 г., 06:06 ч. UTC

Novartis Raises Dividend to CHF3.30 Vs CHF3.20

31.01.2024 г., 06:06 ч. UTC

Novartis 4Q Core Operating Profit $3.82B

31.01.2024 г., 06:05 ч. UTC

Analysts Saw Novartis 4Q Net Profit at $3.75B

31.01.2024 г., 06:05 ч. UTC

Analysts Saw Novartis 4Q Sales at $11.51B

31.01.2024 г., 06:05 ч. UTC

Novartis 4Q Net Profit From Continuing Operatins $2.64B

31.01.2024 г., 06:04 ч. UTC

Novartis 4Q Net Pft $8.48B

31.01.2024 г., 06:03 ч. UTC

Novartis Expects 2024 Core Operating Profit Growth of High Single Digit at Constant Currency

31.01.2024 г., 06:02 ч. UTC

Novartis Expects 2024 Net Sales Growth of Mid Single Digit at Constant Currency

31.01.2024 г., 06:01 ч. UTC

Novartis 4Q Oper Pft $2.58B

31.01.2024 г., 06:00 ч. UTC

Novartis 4Q Sales $11.42B

22.01.2024 г., 06:29 ч. UTC

Sandoz to Acquire Cimerli Business from Coherus for $170M